FBLG Receives US Patent
FBLG - FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound HealingAllowed claims directly support the Company's ongoing Phase 1/2 clinical trial of CYWC628 in patients with diabetic foot ulcers
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.